OU
Oxford University
Oxford University is a seed to Series C stage investment firm. It has made 52 investments. Deal activity decreased year-over-year (1 deal in the last 12 months vs 3 prior). Average disclosed round size is $31.3M (across 35 rounds with reported amounts).
Portfolio
52
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
CT
Chloe Taysom
Investment Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
72 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Allos AI | Seed | $5M | Jan 2026 |
 Wild Bioscience | Series A | — | Oct 2025 |
 SugaROx | Seed | $1.2M | Aug 2025 |
 Ultromics | Series C | $55M | Jul 2025 |
 Mode Labs | Seed | — | May 2025 |
| SugaROx | Seed | — | Jan 2025 |
 Beacon Therapeutics | Series B | $170M | Jul 2024 |
 Oxford Endovascular | Series A | — | May 2024 |
 Oxford Quantum Circuits | Series B | $100M | Mar 2024 |
| YYellowstone Biosciences | Series A | — | Jan 2024 |
| Oxford Quantum Circuits | Series C | $100M | Nov 2023 |
 Navenio | Series A | — | Sep 2023 |
| Beacon Therapeutics | Series B | $120M | Jun 2023 |
 Caristo Diagnostics | Series A | $16.3M | Apr 2023 |
 Refeyn | Series B | — | Apr 2023 |
| OOxomics | Unknown | — | Jan 2023 |
 Quantum Dice | Unknown | — | Jan 2023 |
 Perspectum Diagnostics | Series C | $120M | Jan 2023 |
 Brill Power | Seed | — | Jul 2022 |
 Brill | Series A | $10.5M | Jul 2022 |
 ORCA Computing | Series A | $15M | Jun 2022 |
 Moa Technology | Series A | $44M | May 2022 |
 OMass Therapeutics | Series B | — | Apr 2022 |
| Refeyn | Series B | — | Apr 2022 |
| Brill Power | Series A | $10.5M | Jan 2022 |
Page 1 of 3
Top Co-Investors
Oxford Science Enterprises37 shared
Oxford Investment Consultants12 shared
Parkwalk Advisors8 shared
Shell Ventures4 shared
Legal & General4 shared
Oxford Capital4 shared
Lansdowne Partners4 shared
British Business Bank4 shared
Perivoli Innovations3 shared
Oxford University Innovation3 shared
IP Group plc3 shared
Foresight Ventures3 shared
Northpond Ventures3 shared
Hostplus3 shared
British Patient Capital3 shared
GV3 shared
UTEC3 shared
Barclays2 shared
New Enterprise Associates2 shared
Redmile Group2 shared
Last updated: 20 October 2026